期刊文献+

应用逆转录病毒载体构建荧光标记的K562细胞模型 被引量:2

Establishment of auto-fluorescent K562 cell model using recombinant retrovirus vector
下载PDF
导出
摘要 目的:采用逆转录病毒载体系统构建荧光标记的K562细胞模型。方法:将增强绿色荧光蛋白(EGFP)cDNA插入载体pCMV-hyg,构建重组质粒pCMV-EGFP-hyg,并与逆转录病毒载体质粒pCMV-G和pCMV-GP共转染293T细胞生产重组逆转录病毒,感染K562细胞;通过Hyg筛选建立EGFP自身标记的K562细胞模型。应用流式细胞仪及荧光显微镜观察绿色荧光蛋白表达。比较EGFP-K562细胞与K562细胞生长曲线。通过外周血淋巴细胞的NK活性试验观察EGFP-K562能否用于有关实验研究。结果:应用EGFPcDNA成功构建pCMV-EGFP-hyg,与逆转录病毒载体系统质粒共转染293T细胞后产生含EGFP的重组逆转录病毒,48h收集的病毒滴度达1.5×106CFU/ml。重组逆转录病毒感染K562细胞后,经Hyg筛选,98%以上稳定表达EGFP。长期培养20代,EGFP表达稳定,对K562细胞生长无影响。以EGFP-K562为靶细胞的NK活性试验显示40∶1效靶比,孵育4h最敏感。结论:应用逆转录病毒载体系统成功构建稳定表达绿色荧光蛋白的EGFP-K562细胞模型,NK活性试验提示EGFP-K562可用作实验研究的新型靶细胞模型。 objective:To establish an auto-fluorescent K562 cell model using recombinant retroviral vector system. Methods:The full length cDNA of EGFP gene was inserted into the pCMV-hyg to construct recombinant retroviral plasmid pCMV-EGFP-hyg. The retrovirus containing EGFP was produced by co-transfection of T293 cell line with pCMV-EGFP-hyg, pCMV-G and pCMV-GP. The K562 cells expressing EGFP (EGFP-K562) were obtained by co-culture with recombinant retrovirus-producing T293 cells and Hyg selection. EGFP expression was examined with flow cytometry(FCM) and fluorescence microscopy. To show the application of EGFPK562 in laboratory research, NK activity assay using EGFP-K562 as target cells was carried out in a series of effector (E) to target (T) cell ratio. Results:Recombined retrovirus containing EGFP was successfully constructed with high titers through co-transfection of T293 cells with pCMV-EGFP-hyg, pCMV-G and pCMV-GP. The highest titer of recombinant virus was 1.5×10^6CFU/mL when harvested at time point of 48 hours. Strong fluorescent in EGFP-K562 cells were developed and retained without any change during up to 20 passages of cell culture. More than 98% EGFP-K562 was achieved after selection with Hyg. NK activity assay employing EGFP-K562 as target cells showed peripheral blood mononuclear cells (PMNC) exhibited a different cytotoxicity with different E : T ratio and incubation time. The optimal condition of NK activity assay was at a ratio of 40 : 1 between E and T with 4 h incubation. Conclusion:Auto-fluorescent K562 cells was stably established which might provide a novel cell models in the experimental studies.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2007年第7期656-660,F0002,共6页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省卫生厅重点课题基金资助项目(H200131)
关键词 增强型绿色荧光蛋白 逆转录病毒 流式细胞仪 NK细胞 K562 EGFP retrovirus flow cytometry nature killer cell K562
  • 相关文献

参考文献15

  • 1萨姆布鲁克.分子克隆实验指南[M].3版.北京:科学出版社,2002:387.
  • 2Kantakamalakul W,Jaroenpool J,Pattanapanyasat K,et al.A novel enhanced green fluorescent protein (EGFP)-K562 flow cytometric method for measuring natural killer (NK) cell cytotoxic activity[J].J Immunol Methods,2003,272(1-2):189-197
  • 3Wang ZH,Gao L,Li YY,et al.Induction of apoptosis by buckwheat trypsin inhibitor in chronic myeloid leukemia k562 cells[J].Biol Pharm Bull,2007,30(4):783-786
  • 4Divsalar A,Saboury AA,Yousefi R,et al.Spectroscopic and cytotoxic studies of the novel designed palladium(Ⅱ)complexes:beta-lactoglobulin and K562 as the targets[J].Int J Biol Macromol,2007,40(4):381-386
  • 5Szulawska A,Arkusinska J,Czyz M.Accumulation of gamma-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives[J].Biochem Pharmacol,2007,73 (2):175-184
  • 6Shimomura O.The discovery of aequorin and green fluorescent protein[J].J Micro sc,2005,217 (1):1-15
  • 7Daly CJ,McGrath JC.Fluorescent ligands,antibodies,and proteins for the study of receptors[J].Pharmacol Ther,2003,100(2):101-118
  • 8Bilodeau M,Girard S,Hebert J,et al.A retroviral strategy that efficiently creates chromosomal deletions in mammalian cells[J].Nat Methods,2007,4 (3):263 -268
  • 9Mossoba ME,Medin JA.Cancer immunotherapy using virally transduced dendritic cells:animal studies and human clinical trials[J].Expert Rev Vaccines,2006,5(5):717-732
  • 10Faraoni I,Cottarelli A,Giu liani A,et al.A novel telomerase-based approach to detect natural cell-mediated cytotoxic activity against tumour cells in vitro[J].J Immunol Methods,2005,305 (2):162-172

共引文献1

同被引文献33

  • 1Cortez D, Kadlec L, Pendergast AM. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis[J]. Mol Cell Biol, 1995, 15(10) : 5531-5541.
  • 2Tefferi A, Levine RL, Kantarjian H. Oncogenic signals as treatment targets in classic myeloproliferative neoplasms [ J ]. Biol Blood Marrow Transplant, 2008,15 ( 1 Suppl) : 114-119.
  • 3Druker BJ. Translation of the Philadelphia ehromosome into therapy for CML[J]. Blood, 2008, 112(13) : 4808-4817.
  • 4Scherr M, Battmer K, Winkler T, et al. Specific inhibition of bcrabl gene expression by small interfering RNA [ J ]. Blood, 2003, 101(4) : 1566-1569.
  • 5Ptasznik A, Nakata Y, Kalota A, et al. Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1 ( + ) leukemia cells [ J ]. Nat Med, 2004, 10(11) : 1187-1189.
  • 6Scherr M, Battmer K, Schuhheis B, et al. Stable RNA interference (RNAi) as an option for anti-bcr-abl therapy [ J ]. Gene Ther, 2005, 12( 1 ) : 12-21.
  • 7Bakalova R. RNA interference-about the reality to be exploited in cancer therapy [ J ]. Methods Find Exp Clin Pharmacol, 2007, 29 (6) : 417-421.
  • 8Emig M, Saussele S, Wittor H, et al. Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR[ J]. Leukemia, 1999, 13(11): 1825-1832.
  • 9Jakubowska J, Stasiak M, Szulawska A, et al. Combined effects of doxorubicin and ST1571 on growth, differentiation and apoptosis of CML cell line K562[J]. Acta Biochim Pol, 2007, 54(4) : 839- 846.
  • 10Chaturvedi A, Battmer K, Schaefer D, et al. Comparison between molecularly defined and conventional therapeutics in a conditional BCR-ABL cell culture model [ J ]. Oligonucleotides, 2007, 17 ( 1 ) : 22-34.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部